People with rheumatoid arthritis usually depend on drugs to control pain in their joints. But this summer, the Food and Drug Administration approved a different sort of treatment. It's a device that ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research ...

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease ...

A macrophage-targeted PET/CT tracer predicts anti-TNF response in rheumatoid arthritis at baseline and four weeks, enabling ...

Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the United States alone, it disrupts the lives of about 1.3 million people. The ...